Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure

Gut

Volumn 59, Issue 6, 2010, Pages 817-826

  Li, Chang Yan ^a   Cao, Chuan Zeng ^a   Xu, Wang Xiang ^b   Cao, Meng Meng ^c   Yang, Fan ^d   Dong, Lan ^e   Yu, Miao ^a   Zhan, Yi Qun ^a   Gao, Ya Bing ^a   Li, Wei ^a   Wang, Zhi Dong ^a   Ge, Chang Hui ^a   Wang, Qing Ming ^b   Peng, Rui Yun ^a   Yang, Xiao Ming ^a,b  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b State Key Laboratory of Brain   (China)

^c TIANJIN UNIVERSITY   (China)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CYCLINE; GALACTOSE; LIVER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; PROTEIN BCL XL; RECOMBINANT HEPASSOCIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; LIVER FAILURE; LIVER NECROSIS; LIVER PROTECTION; LIVER REGENERATION; MALE; MITOGENESIS; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; RNA INTERFERENCE; SURVIVAL RATE; SURVIVAL TIME; TOXIC HEPATITIS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; LIVER REGENERATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM PROTEINS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RNA INTERFERENCE;

EID: 77953719118     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.171124     Document Type: Article

References (26)

1. Fleig WE. Liver-specific growth factors. Scand J Gastroenterol Suppl 1988;151:31-6.
2. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991;251:802-4.
3. Mead JE, Fausto N. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989;86:1558-62.
4. Skov Olsen P, Boesby S, Kirkegaard P, et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988;8:992-6.
5. Kan M, Huang JS, Mansson PE, et al. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA 1989;86:7432-6. (Pubitemid 19254470)
6. Mochida S, Ishikawa K, Inao M, et al. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996;226:176-9.
7. Leist M, Gantner F, Bohlinger I, et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-34.
8. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-9.
9. Ryo K, Kamogawa Y, Ikeda I, et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 2000;95:2047-55.
10. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98:71-7. (Pubitemid 24315454)
11. Yamamoto T, Gotoh M, Sasaki H, et al. Molecular cloning and initial characterization of a novel fibrinogen-related gene, HFREP-1. Biochem Biophys Res Commun 1993;193:681-7.
12. Yan J, Yu Y, Wang N, et al. LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Oncogene 2004;23:1939-49.
13. Hara H, Yoshimura H, Uchida S, et al. Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity. Biochim Biophys Acta 2001;1520:45-53.
14. Hara H, Uchida S, Yoshimura H, et al. Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochim Biophys Acta 2000;1492:31-44.
15. Handa Y, Miyazaki M, Sato J. Perfusion technique of suckling rat liver, and comparison of cytologic and biochemical properties between hepatocytes isolated from suckling and adult rats. Res Exp Med (Berl) 1986;186:121-31. (Pubitemid 16071523)
16. Palmes D, Spiegel HU. Animal models of liver regeneration. Biomaterials 2004;25:1601-11.
17. Morikawa A, Sugiyama T, Kato Y, et al. Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect Immun 1996;64:734-8.
18. Yu HT, Yu M, Li CY, et al. Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma. J Biol Chem 2009;284:13335-47.
19. Kaido T, Yamaoka S, Seto S, et al. Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEBS Lett 1997;411:378-82.
20. Husted TL, Lentsch AB. The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury. Curr Pharm Des 2006;12:2867-73.
21. Minuk GY. Hepatic regeneration: if it ain't broke, don't fix it. Can J Gastroenterol 2003;17:418-24.
22. Fausto N. Liver regeneration. J Hepatol 2000;32:19-31.
23. Luedde T, Trautwein C. Intracellular survival pathways in the liver. Liver Int 2006;26:1163-74.
24. Wang X, DeFrances MC, Dai Y, et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 2002;9:411-21.
25. Kosai K, Matsumoto K, Funakoshi H, et al. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999;30:151-9.
26. Phaneuf D, Chen SJ, Wilson JM. Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis. Mol Med 2000;6:96-103.